Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7587-7600, Vol. 21, No. 22
Department of Biochemistry and Molecular
Biology,1 Department of
Urology,2 and Department of
Surgery,3 Norris Comprehensive Cancer Center,
Keck School of Medicine, University of Southern California, Los
Angeles, California 90089-9176
Received 7 June 2001/Returned for modification 30 July
2001/Accepted 16 August 2001
Tumor suppressor gene inactivation is a crucial event in
oncogenesis. Gene inactivation mechanisms include events resulting in
loss of heterozygosity (LOH), gene mutation, and transcriptional silencing. The contribution of each of these different pathways varies
among tumor suppressor genes and by cancer type. The factors that
influence the relative utilization of gene inactivation pathways are
poorly understood. In this study, we describe a detailed quantitative analysis of the three major gene inactivation mechanisms for a model
gene at two different genomic integration sites in mouse embryonic stem
(ES) cells. In addition, we targeted the major DNA methyltransferase
gene, Dnmt1, to investigate the relative contribution of
DNA methylation to these various competing gene inactivation pathways.
Our data show that gene loss is the predominant mode of inactivation of
a herpes simplex virus thymidine kinase neomycin phosphotransferase
reporter gene (HSV-TKNeo) at the two integration sites
tested and that this event is significantly reduced in Dnmt1-deficient
cells. Gene silencing by promoter methylation requires Dnmt1,
suggesting that the expression of Dnmt3a and Dnmt3b alone in ES cells
is insufficient to achieve effective gene silencing. We used a novel
assay to show that missense mutation rates are also substantially
reduced in Dnmt1-deficient cells. This is the first direct
demonstration that DNA methylation affects point mutation rates in
mammalian cells. Surprisingly, the fraction of CpG transition mutations
was not reduced in Dnmt1-deficient cells. Finally, we show that methyl
group-deficient growth conditions do not cause an increase in missense
mutation rates in Dnmt1-proficient cells, as predicted by
methyltransferase-mediated mutagenesis models. We conclude that Dnmt1
deficiency and the accompanying genomic DNA hypomethylation result in a
reduction of three major pathways of gene inactivation in our model system.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.22.7587-7600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Reduced Rates of Gene Loss, Gene Silencing, and
Gene Mutation in Dnmt1-Deficient Embryonic Stem
Cells


*
Corresponding author. Mailing address: USC/Norris
Cancer Center, Room 6418, 1441 Eastlake Ave., Los Angeles, CA
90089-9176. Phone: (323) 865-0650. Fax: (323) 865-0158. E-mail:
plaird{at}hsc.usc.edu.
Present address: Division of Molecular Genetics and Center of
Biomedical Genetics, The Netherlands Cancer Institute, 1066 CX
Amsterdam, The Netherlands.
Present address: Life Sciences Division, Lawrence Berkeley
National Laboratory, Berkeley, CA 94720.
§
Present address: Hubrecht Laboratory/Netherlands Institute for
Developmental Biology, 3584 CT Utrecht, The Netherlands.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»